New publications in health economics and genomics 6th April 2021

Two publications from the past week:

  • Preferences and values for rapid genomic testing in critically ill infants and children: a discrete choice experiment | link
  • Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 30th March 2021

Three publications from the past week:

  • Utility of Genetic Testing from the Perspective of Parents/Caregivers: A Scoping Review | link
  • Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights | link
  • Whole exome sequencing in molecular diagnostics of cancer decreases over time: evidence from a cost analysis in the French setting | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd March 2021

Four publications from the past week:

  • Economic Impact of Coverage Expansion for Non-invasive Prenatal Testing Through a Performance-Based Risk-Sharing Agreement | link
  • Cost of whole genome sequencing for non-typhoidal Salmonella enterica | link
  • Comparison of Decision Modeling Approaches for Health Technology and Policy Evaluation | link
  • Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implications | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th March 2021

Two publications from the past week:

  • Comprehensive Genomic Profiling for Non-Small-Cell Lung Cancer: Health and Budget Impact | link
  • The ethics of resource allocation in translational genomic medicine | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 9th March 2021

Three publications from the past week:

  • Economic evaluation of whole genome sequencing for pathogen identification and surveillance – results of case studies in Europe and the Americas 2016 to 2019 | link
  • Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study | link
  • Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 23rd February 2021

One publication from the past week:

  • Rates of genetic testing in patients prescribed drugs with pharmacogenomic information in FDA-approved labeling | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 16th February 2021

Two publications from the past week:

  • Availability and funding of clinical genomic sequencing globally | link
  • Cost-Effectiveness of Genomic Test-Directed Olaparib for Metastatic Castration-Resistant Prostate Cancer | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

Availability and funding of clinical genomic sequencing globally

Just a quick post to share details of a new paper that was published yesterday in BMJ Global Health.

Phillips KA, Douglas MP, Wordsworth S, et al Availability and funding of clinical genomic sequencing globally BMJ Global Health 2021;6:e004415. Link

This is the latest ouput from the Global Economics and Evaluation of Clinical Genomics Sequencing (GEECS) Working Group, of which I am a founding member.

Our aim in this paper was to examine genome sequencing availability across world regions and countries, using three exemplar countries (UK, Canada, USA) to identify data gaps & funding challenges for implementation. We found that these tests are available or becoming available in every major region of the world, with growing availability in countries with upper-middle-income economies. We conclude by assessing what type of data and initiatives will be needed to better track and understand the use of NGS around the world as such testing continues to expand.

New publications in health economics and genomics 9th February 2021

Three publications from the past week:

  • Value and affordability in precision medicine | link
  • Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases | link
  • Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.

New publications in health economics and genomics 26th January 2021

One publication from the past week:

  • Real-world utilization of biomarker testing for patients with advanced non-small-cell lung cancer in a tertiary referral center and referring hospitals | link

I’m happy to share any other publications from this week that I’ve missed – just let me know. I publish these updates weekly, on a Tuesday, but only if I’ve seen relevant publications. If you don’t see an update on a Tuesday, assume it has been a quiet week for publications in health economics and genomics.